mail
versión imprimible
 
 

HER2-Targeted Therapies Summit 2022

Evvnt Promotion / evvnt
-
14.06.2022 - 16.06.2022  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 09:00 - 17:00
 
Temas de la conferencia
The momentum in anti-HER2 drug development is exploding:

Outcomes for HER2-expressing breast cancer are patients constantly improving; diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 'low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Cecile Geuijen Chief Scientific Officer and Vice President - Oncology, Merus, Shane Olwill Chief Development Officer, Senior Vice President and Head of Translational Science, Pieris Pharmaceuticals and more.
 

Información e inscripción:

https://go.evvnt.com/1003520-2?pid=4832
Ms. Ellie Saunders
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Industry Pricing - Conference + Workshop Day - Standard Rate: USD 4097.0, Industry Pricing - Conference Only - Standard Rate: USD 2899.0
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinCharité International AcademynewTreeÖsterreichische Akademie der ÄrzteEuropean Public Health Association (EUPHA)Helix - Forschung & Beratung WienAMREF - African Medical and Research FoundationEuropean Health Forum Gastein